Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments. The dominant weight loss drugmakers, Novo Nordisk and Eli Lilly, have said … Read more
Market eases expectations for Fed rate cuts Traders have tempered their expectations for a bit for interest rate cuts following cautionary statements from Federal Reserve officials. The probability of a previously much-anticipated March cut tumbled to just 14.5% Monday morning, according to the CME Group’s FedWatch gauge. The expectation had been above 80% just two … Read more
Boxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Danish drugmaker Novo Nordisk‘s parent company, Novo Holdings, on Monday said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost the supply of the highly popular weight loss injection Wegovy and diabetes … Read more
/cdn.vox-cdn.com/uploads/chorus_asset/file/23951320/STK080_VRG_Illo_N_Barclay_5_disney_.jpg)